Skip to main content

Table 2 Mortality and morbidity results of patients in group 1 and group 2

From: Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly

  Group 1 (< 65 years old) Group 2 (≥ 65 years old) p
Total hospital stay (days) median (range) 22.0 (5–306) 22.5 (6–157) 0.925
ICU stay (days) median (range) 2.0 (0–71) 2.0 (1–101) 0.629
HDU stay (days) median (range) 3.0 (0–39) 2.0 (0–39) 0.831
Hospital death n (%) 10 (2) 4 (3) 0.607
Complication grade n (%)    0.644
 0 88 (18) 25 (20)  
 I 19 (4) 8 (6)  
 II 166 (34) 42 (34)  
 III 125 (26) 31 (25)  
 IV 89 (18) 18 (15)  
Tumour-related OS median (months) (95 % CI)    0.889
 CRC (n = 184) 27.0 (20.4–33.6) 42.0 (30.1–53.3) 0.130
 PMP (n = 157) MNR MNR 0.356
 Mesothelioma (n = 53) 62.0 (17.2–106.8) 22.0 (5.5–38.5) 0.186
 Appendiceal cancer (n = 137) 64.0 (55.4–72.6) 43.0 (28.5–57.5) 0.475
 Others (n = 80) 25.0 (16.8–33.2) 24.0 (4.8–43.2) 0.664